All other professional, scientific and technical activities n.e.c.
TRES BIOTECHNOLOGY AS
Revenue 2025
NOK 0
Operating profit
NOK −6,000
Equity
NOK 148,000
Incorporated
2023
Share capital
NOK 30,000
Roles
Daglig lederBjørn Tore Gjertsen
Styrets lederBjørn Tore Gjertsen
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| BJØRN TORE GJERTSEN | 50.0% | 500.000000 | 2025 |
| LIV TURID BERTELSEN | 50.0% | 500.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| HÁ BIOTECH AS | Active | 40.0% | 1320000.000000 |
| BJØRGVIN THERAPEUTICS GROUP AS | Active | 14.5% | 7250.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.